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Objectives: to determine whether application of fibrin glue before closure of inguinal wounds reduces the incidence of
lymphatic complications.
Design: we a prospective randomised trial.
Materials and methods: 224 consecutive patients were enrolled. The wounds were randomly assigned to standard closure
(group A, n 134) or closure with application of fibrin glue (group B, n 132). The incidence of local lymphatic and non-
lymphatic complications, the amount of lymphatic fluid collected, and the time to drain removal were compared in the
groups.
Results: the incidence of lymphatic complications was 19% in group A and 10% in group B (p 0.027). The average drain
output and the time to drain removal did not differ in the two groups. The total incidence of non-lymphatic local
complications was 10% and did not differ in the two groups.
Conclusions: fibrin glue application is associated with a significant reduction in lymphatic complications.
Key Words: Randomised controlled trial; Vascular surgical procedures; Fibrin tissue adhesive; Postoperative
complications; Lymphocele.
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The exposure of femoral vessels during surgical pro-
cedures can lead to local wound complications such as
lymphatic fistula, lymphocele, delayed healing, skin
necrosis and infection. Seemingly minor complica-
tions are worrisome because they can lead to infection
of the local structures or the underlying graft.1,2 As a
consequence treatment costs are increased3,4 and the
limb and the life of the patient may be jeopardized.2,5,6
The use of fibrin glue in gaining haemostatic control
in vascular surgery is well documented.7±11 Fibrin
glue may also be an effective therapy for lymphatic
complications such as fistulas and lymphoceles.12,13
Never to date, prophylactic sealing of wounds with
fibrin glue has only been evaluated after axillary and
inguinal lymphadenectomy for cancer.12,14±19
The aim of this prospective randomised study was
to determine whether the prophylactic application ofPlease address all correspondence to: L. Giovannacci, Surgical
Department, Buergerspital Solothurn, 4500 Solothurn, Switzerland.




All patients over the age of 20 years undergoing
exposure of the femoral artery was studied. For an
estimated rate of lymphatic complications of 20% a
sample size of 108 wounds was required to detect as
halving as lymphatic complications (alpha 0.5 and
power 80%). A total of 224 consecutive patients with
a mean age of 69 years (32±97 years) were enrolled in
the study. Unilateral or bilateral inguinal exposures
were performed for a total of 279 inguinal wounds
over 2.5 years ending in January 2001. The inguinal
wounds were randomly assigned to group A, wound
closure without fibrin glue, and Group B, wound clo-
sure with application of fibrin glue. 266 inguinal
wounds were included in the final analysis (seell rights reserved.
Fibrin Glue Reduces Groin Lymphatic Complications 197Fig. 1). The study protocol was approved by the ethic-
al committee of the surgical department of the univer-
sity of Basel.
Procedure
The surgical exposure of the femoral vessels in the
groin was standardised. A longitudinal incision was
placed 2±3 cm lateral to the course of the femoral
artery. A limited subcutaneous flap was displaced
medially in order to prevent damage of lymphatic
vessels and lymph nodes. The femoral vessels
were then exposed in a vertical plane parallel to their
longitudinal axis. If a lymphatic leak became visible,
the injured lymphatic vessels were ligated or electro-
coagulated. The wound was subsequently closed in
a meticulous layered fashion after insertion of a sub-
cutaneous wound drainage tube. The wounds were
randomly assigned to group A and group B after
closure of the fascia. The wounds of group A were
closed without fibrin glue, the wounds of group B
were closed with application of 1 ml fibrin
glue (Tissucol1; Baxter AG, Volketswil). The fibrin
glue was spread with a syringe on the largest possible
surface of the deep subcutaneous tissue and of
the fascia. For randomisation we had two containers
with numbered closed envelopes in the operating
room, one for unilateral and one for bilateral proce-
dures. For unilateral operation the envelope contained
the instruction if fibrin glue had to be utilised or not.
For bilateral operations the envelope contained the
instruction about which inguinal wound had to be
sealed with fibrin glue. The contralateral wound was
assigned to the control group.
Assessments
The incidence of lymphatic and non-lymphatic com-
plications, the amount and gross appearance of fluid
collected in the drain and the time to drain removal
were recorded prospectively. Lymphorrhoea was
defined as perfusion of clear lymphatic fluid at the
operative wound site. Lymphatic fistula was defined
as the production of more than 30 ml clear fluid
per day at the operative wound site lasting more
than 3 days following the procedure, or persistent
lymphatic leakage for more than 5 days after the
procedure regardless of the amount of fluid. Lympho-
cele was defined as subcutaneous collection of
clear fluid without infection or haematoma. If a lym-
phocele was suspected the groin was examined using
ultrasound.Treatment of inguinal complications
The treatment of inguinal complications was initially
conservative, including bed rest, elevation of the
extremity, wound cleaning and compressive bandage.
Bacterial cultures of the wound fluid were obtained in
every case. If conservative treatment failed, the
wound was reexplored surgically, with curettage of
the cavity, ligation of lymphatic vessels and applica-
tion of fibrin glue to seal the dissected surfaces.
Statistical analysis
For statistical analysis a two-tailed Fisher's exact test
and Chi-square test were used. A multivariate analy-
sis (one way analysis of variance) to determine which
clinical features were associated with developing
wound complications was also done. Statistical sig-
nificance was determined at the p5 0.05 level.
Relative risk and 95% confidence interval (CI 95%)
were also computed.
Results
A total of 266 groin wounds were randomised and
available for analysis. Group A, without fibrin glue,
included 134 wounds (81 wounds from patients with
unilateral procedure and 53 from patients with bilat-
eral procedure), group B, with fibrin glue, included
132 wounds (79 from patients with unilateral proce-
dure, 53 from patients with bilateral procedure). The
two groups did not differ with respect to age, gender,
comorbidity or proportion of urgent operations
(Table 1); nor was there any difference between the
two groups in the indications for surgery (Table 2).
Lymphatic complications
The incidence of lymphatic complications was 19% in
group A, and 10% in group B (p 0.027) (Table 3) with
a relative risk of 1.4 for group A versus group B (95%
CI, 1.1±1.9). In group A two of the lymphatic fistulas
were associated with superficial infections and four
were associated with deep infections. In group B four
lymphatic fistulas were associated with superficial
infections and none were associated with deep infec-
tions. Most of the lymphatic complications were
treated conservatively. Five complicated wounds in
each group had to be treated surgically. In group A
there were three simple wound explorations with cur-
ettage, ligation of the lymphatics and wound sealing.Eur J Vasc Endovasc Surg Vol 24, September 2002
Table 1. Characteristics of patients in the two treatment groups.
Variable Unilateral exposure p Bilateral exposure
(Group A and B)
Group A Group B
No. of patients 81 79 53
Mean age (years) 72 70 0.36 63
Gender 0.63
Men (%) 45 (56) 40 (51) 41 (77)
Women (%) 35 (44) 38 (49) 12 (23)
Urgent operations (%) 14 (18) 21 (27) 0.25 6 (11)
Redo operations (%) 13 (16) 7 (9) 0.23 4 (7)
Table 2. Comorbidities and indications for surgery in the two treatment groups.
Variable Unilateral exposure p Bilateral exposure
No. (%) of patients No. (%) of patients
Group A Group B (Group A and B)
Comorbidity
Renal failure 11 (14) 7 (9) 0.45 8 (15)
Heart failure 31 (38) 28 (35) 0.74 16 (30)
Obesity 25 (31) 21 (27) 0.60 12 (23)
Diabetes 22 (27) 18 (23) 0.59 11 (21)
Chronic venous insuff. 8 (10) 9 (11) 0.80 5 (9)
Indication for surgery
Aneurysm 11 (27) 9 (11) 0.81 5 (9)
Chronic occlusive disease 51 (63) 50 (63) 1.0 37 (70)
Aneurysm and chronic occlusive disease 0 (0) 1 (1) 0.49 6 (11)
Acute occlusion 19 (23) 17 (22) 0.85 4 (7)
Other 0 (0) 2 (2) 0.24 1 (2)
Table 3. Lymphatic complications in the two treatment groups.
Variable No. (%) of cases p value
Group A Group B
Lymphfistula 15 (11) 7 (5)
Lymphfistula with
superficial infection
2 (1) 4 (3)
Lymphfistula with
deep infection
4 (3) 0 (0)
Lymphocele 5 (4) 2 (1)
Total 26 (19) 13 (10) 0.03
198 L. Giovannacci et al.In one case a wound revision was performed and
1 week thereafter a sartorius myoplasty was needed.
In one further case, with fistula and deep infection, the
leg had to be amputated 10 days after the vascular
procedure because of worsening ischaemia due to
graft occlusion. Removal of the infected vascular pros-
thesis was needed in the following days. In group B
there were four simple wound explorations with liga-
tion of the lymphatics and fibrin sealing. In one case
the procedure had to be repeated twice.Eur J Vasc Endovasc Surg Vol 24, September 2002In the subgroup of 39 patients with lymphatic com-
plications 15 (38%) had a prolonged hospital stay
because of wound complications, two (5%) had to be
readmitted and 12 (31%) needed additional consulta-
tions as out-patients.
We did not find a difference between groups
for drain output from the wound. Median drain out-
put was 30 ml (0±1100 ml) in group A and 30 ml (0±
3805 ml) in group B. The time to drain removal did not
differ between the two groups: 2.6 days vs 2.7 days.
Non-lymphatic complications
The total incidence of non-lymphatic local complica-
tions did not differ between the groups. Two cases
of delayed healing were observed in group A and
three in group B. Group A had five infections,
group B, six. Two cases of skin necrosis occurred in
group A. Four of the complications of group A and
two of the complications of group B needed surgical
treatment.
Fig. 1. Flow diagram.
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The data were analysed for risk factors for the
development of groin lymphatic complications. There
were, however, no statistically significant correlations
between comorbidity (renal failure, heart failure,
obesity, diabetes and chronic venous insufficiency)
and lymphatic complications. Redo operations were
not at an increased risk of developing lymphatic com-
plications in our series: two lymphatic complications
occurred in 24 redo operations (8%). Mean body mass
index (24.7 kg/cm2) and mean age (69 years) were the
same in patients with and without lymphatic compli-
cations. Similarly, sex did not influence the lymphatic
complication rates, which were in 25/167 (15%) in men
and 14/97 (14%) in women.
Discussion
Groin lymphatic fistula and lymphocele are probably
due to disruption of lymphatic channels related to
the long saphenous vein in the Scarpa triangle.12
A lymphatic leak can lead to a subcutaneous fluid
collection in the form of a lymphocele or to a flow of
lymphatic fluid through the wound or through the
channel of the drainage tube, representing a lymphatic
fistula.20±23 Lymphatic complications are a well-
recognised problem in most busy vascular surgery
services, although they are generally described
as uncommon.3,22,24±26Fibrin glue is frequently used in vascular surgery,
especially to stop diffuse local bleeding and for
sealing vein lesions and bleeding vascular ana-
stomosis.7±11 There are reports of the efficacious thera-
peutic use of fibrin glue to close lymphatic fistulas.12,13
The concept that fibrin glue can seal lymphatic
vessels and prevent the formation of a cavity between
the dissection layers, was the rationale for the pro-
phylactic application of fibrin glue in the inguinal
wound to avoid lymphatic complications. Our results
show that this procedure can significantly reduce the
complication rate from 19% to 10%.
A wound complication in the groin is a serious
problem, because it represents a risk for infection,
eventually involving a graft, that may jeopardise the
limb and life of the patient.1±3,5,6 Previous reports
show an association between wound complication
and infection in up to 18% of cases.2,5 Our results
showed an association between lymphatic fistula and
infection in 31% of cases. Not only infections are of
concern. Even minor complications can cause dis-
comfort for the patient and increased treatment costs.
In the subgroup of patients with lymphatic complica-
tions we found that the hospital stay was prolonged
because of wound complication in 38%, 5% had to
be readmitted, and 31% had prolonged treatment as
out-patients, thereby increasing treatment costs. On
the other hand the application of fibrin glue causes
costs of about 100 Euro for every inguinal wound.
The number of patients treated surgically for
lymphatic complication was the same in both groups,Eur J Vasc Endovasc Surg Vol 24, September 2002
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In group A without fibrin glue application, there was
one leg amputation due to graft occlusion, probably
related to a deep infection following a groin lymphatic
fistula, one removal of an infected vascular pro-
sthesis, and one sartorius myoplasty. In group B,
with fibrin glue application, only simple secondary
wound explorations were needed.
Unlike our experience the prophylactic application
of fibrin glue in inguinal or axillary lymph-
adenectomy led to a modest reduction of lymphatic
complications or only to a reduction of lymphatic
flow.12,14±19 A possible explanation, for this limited
efficacy, compared with our results, is that the high
lymphatic flow, expected after lymphadenectomy,
may eliminate the fibrin glue, before it can adhere to
a dissected surface.
Our definition of a lymphatic fistula is very
precise, in view of the clinical importance of even
minor complications. We define a lymphatic fistula
as perfusion of more than 30 ml clear fluid per day at
the operative wound site lasting more than 3 days
after the procedure, or persistent lymphatic leakage
for more than 5 days after the procedure, regardless
of the amount of fluid. This is why we recorded a
higher frequency of complications (19% in the group
without fibrin glue application) compared with
prospective studies reported in the literature: Kent
et al.3 reported a frequency of 10% and Gordon
et al.,27 a frequency of 4%. The definition of lymphatic
complication in these studies was vague: Gordon
defined a concept of `` clinically significant groin
fluid collection'', Kent defined a fistula only if the
patient needed a dressing change several times a
day. These definitions result in selection of the major
complications.
To confirm our results and to recommend the
closure of inguinal wounds with fibrin glue as a
standard method, further eventually multicentre-
based studies are needed. To allow a comparison,
these studies have to define the lymphatic complica-
tions precisely.
The rates of non-lymphatic complications were
similar to those previously reported in the literature.
The rates we found were 4% infections, 2% delayed
healing and 1% skin necrosis. The literature shows
frequencies of infections ranging from 1 to 25%,
frequencies of delayed healing of from 1 to 6%
and of skin necrosis, of up to 5%.3,20,24,25,27,28 The
application of fibrin glue did not influence this cat-
egory of complications.
Previous reports in the literature show many risk
factors for developing groin lymphatic complications,
such as redo operations,23,25 diabetes,4 and obesity.3Eur J Vasc Endovasc Surg Vol 24, September 2002We did not find any risk factors among redo opera-
tions, comorbidity, age or sex.
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